Targeting IL-17A attenuates neonatal sepsis mortality induced by IL-18
James L. Wynn(University of Florida), Daniel J. Moore(Vanderbilt University Medical Center), Hector R. Wong(Cincinnati Children's Hospital Medical Center), Mansour Mohamadzadeh(The University of Texas at San Antonio Health Science Center), Edward R. Sherwood(East Tennessee State University), John T. Benjamin(Vanderbilt University), Patrick Lahni(Cincinnati Children's Hospital Medical Center), Philip O. Scumpia(University of California, Los Angeles), Irina Zharkikh(University of Florida), Chris S. Wilson(Vanderbilt University), Steven J. McElroy(Vanderbilt University Medical Center), Erin J. Plosa(Vanderbilt University), Lyle L. Moldawer(University of Florida), Jörn-Hendrik Weitkamp(Vanderbilt University Medical Center), Ricardo Ungaro(University of Florida), Jacek Hawiger(VA Tennessee Valley Healthcare System), Andrew Marshall(Vanderbilt University), Jinhua Liu(Guangdong Medical College), Henry V. Baker(University of Florida), M. Cecilia López(University of Florida), Natacha Colliou(University of Florida)
Cited by 113
Related Papers
Genomic responses in mouse models poorly mimic human inflammatory diseases
|Proceedings of the National Academy of Sciences|2013|3k
Gut Dysbiosis Is Linked to Hypertension
|Hypertension|2015|1.5k
Surviving Sepsis Campaign International Guidelines for the Management of Septic Shock and Sepsis-Associated Organ Dysfunction in Children
|Pediatric Critical Care Medicine|2020|1.2k
Classification of patients with sepsis according to blood genomic endotype: a prospective cohort study
|The Lancet Respiratory Medicine|2017|632
Trained immunity, tolerance, priming and differentiation: distinct immunological processes
|Nature Immunology|2020|591